Huntington National Bank’s GENENTECH INC DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95 Hold
1
﹤0.01% 2619
2025
Q4
$95 Hold
1
﹤0.01% 2542
2025
Q3
$95 Hold
1
﹤0.01% 2632
2025
Q2
$95 Hold
1
﹤0.01% 2677
2025
Q1
$95 Hold
1
﹤0.01% 2710
2024
Q4
$95 Hold
1
﹤0.01% 2736
2024
Q3
$95 Hold
1
﹤0.01% 2732
2024
Q2
$95 Hold
1
﹤0.01% 2703
2024
Q1
$95 Hold
1
﹤0.01% 2519
2023
Q4
$95 Hold
1
﹤0.01% 2434
2023
Q3
$95 Hold
1
﹤0.01% 2417
2023
Q2
$95 Hold
1
﹤0.01% 2389
2023
Q1
$95 Hold
1
﹤0.01% 2224
2022
Q4
$95 Hold
1
﹤0.01% 2085
2022
Q3
$0 Hold
1
﹤0.01% 2938
2022
Q2
$0 Hold
1
﹤0.01% 2941
2022
Q1
$0 Hold
1
﹤0.01% 2867
2021
Q4
$0 Hold
1
﹤0.01% 2794
2021
Q3
$0 Hold
1
﹤0.01% 2518
2021
Q2
$0 Hold
1
﹤0.01% 2406
2021
Q1
$0 Hold
1
﹤0.01% 2296
2020
Q4
$0 Hold
1
﹤0.01% 2273
2020
Q3
$0 Hold
1
﹤0.01% 2219
2020
Q2
$0 Hold
1
﹤0.01% 2232
2020
Q1
$0 Hold
1
﹤0.01% 2327
2019
Q4
$0 Hold
1
﹤0.01% 2337
2019
Q3
$0 Hold
1
﹤0.01% 2243
2019
Q2
$0 Buy
+1
New ﹤0.01% 2277
2019
Q1
Sell
-1
Closed 2275
2018
Q4
$0 Hold
1
﹤0.01% 2329
2018
Q3
$0 Buy
+1
New ﹤0.01% 2315

Huntington National Bank's DNA Position: Q1 2026 in Review

Huntington National Bank held its GENENTECH INC (DNA) position steady in Q1 2026 at 1 share worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Huntington National Bank first reported a position in DNA in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds DNA as of Q1 2026.

  • Huntington National Bank held 1 share of GENENTECH INC worth $95 as of Q1 2026.
  • Huntington National Bank left its GENENTECH INC share count unchanged in Q1 2026.
  • GENENTECH INC made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2619 holding.
  • Huntington National Bank first reported a position in GENENTECH INC in Q3 2018 and has held it in 30 quarters since.
  • 1 fund tracked by Wall St. Rank held GENENTECH INC as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.